Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 979 entries
Sorted by: Best Match Show Resources per page
Synthesis of MOF-525 Derived Nanoporous Carbons with Different Particle Sizes for Supercapacitor Application.

Chemistry, an Asian journal

Chang TH, Young C, Lee MH, Salunkhe RR, Alshehri SM, Ahamad T, Islam MT, Wu KC, Hossain MSA, Yamauchi Y, Ho KC.
PMID: 28977735
Chem Asian J. 2017 Nov 02;12(21):2857-2862. doi: 10.1002/asia.201701082. Epub 2017 Oct 04.

Nanoporous carbon (NC) materials have attracted great research interest for supercapacitor applications, because of their excellent electrochemical and mechanical stability, good electrical conductivity, and high surface area. Although there are many reports on metal-organic framework (MOF)-derived carbon materials, previous...

Cite
Chang TH, Young C, Lee MH, et al. Synthesis of MOF-525 Derived Nanoporous Carbons with Different Particle Sizes for Supercapacitor Application. Chem Asian J. 2017;12(21):2857-2862doi: 10.1002/asia.201701082.
Chang, T. H., Young, C., Lee, M. H., Salunkhe, R. R., Alshehri, S. M., Ahamad, T., Islam, M. T., Wu, K. C., Hossain, M. S. A., Yamauchi, Y., & Ho, K. C. (2017). Synthesis of MOF-525 Derived Nanoporous Carbons with Different Particle Sizes for Supercapacitor Application. Chemistry, an Asian journal, 12(21), 2857-2862. https://doi.org/10.1002/asia.201701082
Chang, Ting-Hsiang, et al. "Synthesis of MOF-525 Derived Nanoporous Carbons with Different Particle Sizes for Supercapacitor Application." Chemistry, an Asian journal vol. 12,21 (2017): 2857-2862. doi: https://doi.org/10.1002/asia.201701082
Chang TH, Young C, Lee MH, Salunkhe RR, Alshehri SM, Ahamad T, Islam MT, Wu KC, Hossain MSA, Yamauchi Y, Ho KC. Synthesis of MOF-525 Derived Nanoporous Carbons with Different Particle Sizes for Supercapacitor Application. Chem Asian J. 2017 Nov 02;12(21):2857-2862. doi: 10.1002/asia.201701082. Epub 2017 Oct 04. PMID: 28977735.
Copy Download .nbib Format: NLM
Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer.

Annals of surgical oncology

Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T.
PMID: 26170193
Ann Surg Oncol. 2015 Dec;22:S1616. doi: 10.1245/s10434-015-4732-8.

No abstract available.

Cite
Aoyama T, Kawabe T, Fujikawa H, et al. Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015;22:S1616doi: 10.1245/s10434-015-4732-8.
Aoyama, T., Kawabe, T., Fujikawa, H., Hayashi, T., Yamada, T., Tsuchida, K., Yukawa, N., Oshima, T., Rino, Y., Masuda, M., Ogata, T., Cho, H., & Yoshikawa, T. (2015). Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Annals of surgical oncology, 22S1616. https://doi.org/10.1245/s10434-015-4732-8
Aoyama, Toru, et al. "Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer." Annals of surgical oncology vol. 22 (2015): S1616. doi: https://doi.org/10.1245/s10434-015-4732-8
Aoyama T, Kawabe T, Fujikawa H, Hayashi T, Yamada T, Tsuchida K, Yukawa N, Oshima T, Rino Y, Masuda M, Ogata T, Cho H, Yoshikawa T. Erratum to: Loss of Lean Body Mass as an Independent Risk Factor for Continuation of S-1 Adjuvant Chemotherapy for Gastric Cancer. Ann Surg Oncol. 2015 Dec;22:S1616. doi: 10.1245/s10434-015-4732-8. PMID: 26170193.
Copy Download .nbib Format: NLM
Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy.

Oncology letters

Higuchi A, Oshima T, Yoshihara K, Sakamaki K, Aoyama T, Suganuma N, Yamamoto N, Sato T, Cho H, Shiozawa M, Yoshikawa T, Rino Y, Kunisaki C, Imada T, Masuda M.
PMID: 28356977
Oncol Lett. 2017 Feb;13(2):905-911. doi: 10.3892/ol.2016.5494. Epub 2016 Dec 14.

Overall survival remains unsatisfactory in stage II/III gastric cancer, even after curative surgery and adjuvant chemotherapy. Platelet-derived growth factor receptor-β (

Cite
Higuchi A, Oshima T, Yoshihara K, et al. Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy. Oncol Lett. 2016;13(2):905-911doi: 10.3892/ol.2016.5494.
Higuchi, A., Oshima, T., Yoshihara, K., Sakamaki, K., Aoyama, T., Suganuma, N., Yamamoto, N., Sato, T., Cho, H., Shiozawa, M., Yoshikawa, T., Rino, Y., Kunisaki, C., Imada, T., & Masuda, M. (2017). Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy. Oncology letters, 13(2), 905-911. https://doi.org/10.3892/ol.2016.5494
Higuchi, Akio, et al. "Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy." Oncology letters vol. 13,2 (2017): 905-911. doi: https://doi.org/10.3892/ol.2016.5494
Higuchi A, Oshima T, Yoshihara K, Sakamaki K, Aoyama T, Suganuma N, Yamamoto N, Sato T, Cho H, Shiozawa M, Yoshikawa T, Rino Y, Kunisaki C, Imada T, Masuda M. Clinical significance of platelet-derived growth factor receptor-β gene expression in stage II/III gastric cancer with S-1 adjuvant chemotherapy. Oncol Lett. 2017 Feb;13(2):905-911. doi: 10.3892/ol.2016.5494. Epub 2016 Dec 14. PMID: 28356977; PMCID: PMC5351282.
Copy Download .nbib Format: NLM
Preoperative gluteus medius muscle atrophy as a predictor of walking ability after total hip arthroplasty.

Physical therapy research

Nankaku M, Tsuboyama T, Aoyama T, Kuroda Y, Ikeguchi R, Matsuda S.
PMID: 28289576
Phys Ther Res. 2016 Jul 14;19(1):8-12. doi: 10.1298/ptr.e9884. eCollection 2016.

PURPOSE: To elucidate the relation between certain preoperative physical parameters and walking with a limp after total hip arthroplasty (THA) and determine whether it is possible to predict the walking ability of patients 6 months after THA.METHODS: The subjects...

Cite
Nankaku M, Tsuboyama T, Aoyama T, et al. Preoperative gluteus medius muscle atrophy as a predictor of walking ability after total hip arthroplasty. Phys Ther Res. 2016;19(1):8-12doi: 10.1298/ptr.e9884.
Nankaku, M., Tsuboyama, T., Aoyama, T., Kuroda, Y., Ikeguchi, R., & Matsuda, S. (2016). Preoperative gluteus medius muscle atrophy as a predictor of walking ability after total hip arthroplasty. Physical therapy research, 19(1), 8-12. https://doi.org/10.1298/ptr.e9884
Nankaku, Manabu, et al. "Preoperative gluteus medius muscle atrophy as a predictor of walking ability after total hip arthroplasty." Physical therapy research vol. 19,1 (2016): 8-12. doi: https://doi.org/10.1298/ptr.e9884
Nankaku M, Tsuboyama T, Aoyama T, Kuroda Y, Ikeguchi R, Matsuda S. Preoperative gluteus medius muscle atrophy as a predictor of walking ability after total hip arthroplasty. Phys Ther Res. 2016 Jul 14;19(1):8-12. doi: 10.1298/ptr.e9884. eCollection 2016. PMID: 28289576; PMCID: PMC5342965.
Copy Download .nbib Format: NLM
Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society.

Esophagus : official journal of the Japan Esophageal Society

Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, Shimada H, Takiuchi H, Toh Y, Doki Y, Naomoto Y, Matsubara H, Miyazaki T, Muto M, Yanagisawa A.
PMID: 25620903
Esophagus. 2015;12:1-30. doi: 10.1007/s10388-014-0465-1. Epub 2014 Nov 11.

No abstract available.

Cite
Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2014;12:1-30doi: 10.1007/s10388-014-0465-1.
Kuwano, H., Nishimura, Y., Oyama, T., Kato, H., Kitagawa, Y., Kusano, M., Shimada, H., Takiuchi, H., Toh, Y., Doki, Y., Naomoto, Y., Matsubara, H., Miyazaki, T., Muto, M., & Yanagisawa, A. (2015). Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society. Esophagus : official journal of the Japan Esophageal Society, 121-30. https://doi.org/10.1007/s10388-014-0465-1
Kuwano, Hiroyuki, et al. "Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society." Esophagus : official journal of the Japan Esophageal Society vol. 12 (2015): 1-30. doi: https://doi.org/10.1007/s10388-014-0465-1
Kuwano H, Nishimura Y, Oyama T, Kato H, Kitagawa Y, Kusano M, Shimada H, Takiuchi H, Toh Y, Doki Y, Naomoto Y, Matsubara H, Miyazaki T, Muto M, Yanagisawa A. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1-30. doi: 10.1007/s10388-014-0465-1. Epub 2014 Nov 11. PMID: 25620903; PMCID: PMC4297610.
Copy Download .nbib Format: NLM
Overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis complicated with hepatocellular carcinoma.

Clinical journal of gastroenterology

Fukuda K, Kogita S, Tsuchimoto Y, Sawai Y, Igura T, Ohama H, Makino Y, Matsumoto Y, Nakahara M, Zushi S, Imai Y.
PMID: 26182318
Clin J Gastroenterol. 2012 Jun;5(3):183-8. doi: 10.1007/s12328-012-0294-5. Epub 2012 Apr 07.

Development of hepatocellular carcinoma (HCC) in patients with autoimmune liver disease is less common than in those with other types of chronic liver disease. Here we report a rare case of overlap syndrome consisting of autoimmune hepatitis (AIH) and...

Cite
Fukuda K, Kogita S, Tsuchimoto Y, et al. Overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis complicated with hepatocellular carcinoma. Clin J Gastroenterol. 2012;5(3):183-8doi: 10.1007/s12328-012-0294-5.
Fukuda, K., Kogita, S., Tsuchimoto, Y., Sawai, Y., Igura, T., Ohama, H., Makino, Y., Matsumoto, Y., Nakahara, M., Zushi, S., & Imai, Y. (2012). Overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis complicated with hepatocellular carcinoma. Clinical journal of gastroenterology, 5(3), 183-8. https://doi.org/10.1007/s12328-012-0294-5
Fukuda, Kazuto, et al. "Overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis complicated with hepatocellular carcinoma." Clinical journal of gastroenterology vol. 5,3 (2012): 183-8. doi: https://doi.org/10.1007/s12328-012-0294-5
Fukuda K, Kogita S, Tsuchimoto Y, Sawai Y, Igura T, Ohama H, Makino Y, Matsumoto Y, Nakahara M, Zushi S, Imai Y. Overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis complicated with hepatocellular carcinoma. Clin J Gastroenterol. 2012 Jun;5(3):183-8. doi: 10.1007/s12328-012-0294-5. Epub 2012 Apr 07. PMID: 26182318.
Copy Download .nbib Format: NLM
Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease.

Hepatology research : the official journal of the Japan Society of Hepatology

Fukushima H, Yamashina S, Arakawa A, Taniguchi G, Aoyama T, Uchiyama A, Kon K, Ikejima K, Watanabe S.
PMID: 29473277
Hepatol Res. 2018 Aug;48(9):757-767. doi: 10.1111/hepr.13071. Epub 2018 Apr 10.

AIM: Hepatic inclusion composed of autophagy-specific substrate p62 is one of the histological features of non-alcoholic fatty liver disease (NAFLD) and can be a precursor to hepatic carcinogenesis. The expression of p62 was enhanced by not only autophagic dysfunction...

Cite
Fukushima H, Yamashina S, Arakawa A, et al. Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease. Hepatol Res. 2018;48(9):757-767doi: 10.1111/hepr.13071.
Fukushima, H., Yamashina, S., Arakawa, A., Taniguchi, G., Aoyama, T., Uchiyama, A., Kon, K., Ikejima, K., & Watanabe, S. (2018). Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease. Hepatology research : the official journal of the Japan Society of Hepatology, 48(9), 757-767. https://doi.org/10.1111/hepr.13071
Fukushima, Hirofumi, et al. "Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease." Hepatology research : the official journal of the Japan Society of Hepatology vol. 48,9 (2018): 757-767. doi: https://doi.org/10.1111/hepr.13071
Fukushima H, Yamashina S, Arakawa A, Taniguchi G, Aoyama T, Uchiyama A, Kon K, Ikejima K, Watanabe S. Formation of p62-positive inclusion body is associated with macrophage polarization in non-alcoholic fatty liver disease. Hepatol Res. 2018 Aug;48(9):757-767. doi: 10.1111/hepr.13071. Epub 2018 Apr 10. PMID: 29473277.
Copy Download .nbib Format: NLM
Fast crystalline ice formation at extremely low temperature through water/neon matrix sublimation.

Physical chemistry chemical physics : PCCP

Hama T, Ishizuka S, Yamazaki T, Kimura Y, Kouchi A, Watanabe N, Sugimoto T, Pirronello V.
PMID: 28671232
Phys Chem Chem Phys. 2017 Jul 21;19(27):17677-17684. doi: 10.1039/c7cp03315j. Epub 2017 Jul 03.

Crystalline ice formation requires water molecules to be sufficiently mobile to find and settle on the thermodynamically most stable site. Upon cooling, however, diffusion and rearrangement become increasingly kinetically difficult. Water ice grown by the condensation of water vapor...

Cite
Hama T, Ishizuka S, Yamazaki T, et al. Fast crystalline ice formation at extremely low temperature through water/neon matrix sublimation. Phys Chem Chem Phys. 2017;19(27):17677-17684doi: 10.1039/c7cp03315j.
Hama, T., Ishizuka, S., Yamazaki, T., Kimura, Y., Kouchi, A., Watanabe, N., Sugimoto, T., & Pirronello, V. (2017). Fast crystalline ice formation at extremely low temperature through water/neon matrix sublimation. Physical chemistry chemical physics : PCCP, 19(27), 17677-17684. https://doi.org/10.1039/c7cp03315j
Hama, Tetsuya, et al. "Fast crystalline ice formation at extremely low temperature through water/neon matrix sublimation." Physical chemistry chemical physics : PCCP vol. 19,27 (2017): 17677-17684. doi: https://doi.org/10.1039/c7cp03315j
Hama T, Ishizuka S, Yamazaki T, Kimura Y, Kouchi A, Watanabe N, Sugimoto T, Pirronello V. Fast crystalline ice formation at extremely low temperature through water/neon matrix sublimation. Phys Chem Chem Phys. 2017 Jul 21;19(27):17677-17684. doi: 10.1039/c7cp03315j. Epub 2017 Jul 03. PMID: 28671232.
Copy Download .nbib Format: NLM
Comprehensive analysis of prokaryotes in environmental water using DNA microarray analysis and whole genome amplification.

Pathogens (Basel, Switzerland)

Akama T, Kawashima A, Tanigawa K, Hayashi M, Ishido Y, Luo Y, Hata A, Fujitani N, Ishii N, Suzuki K.
PMID: 25437334
Pathogens. 2013 Oct 30;2(4):591-605. doi: 10.3390/pathogens2040591.

The microflora in environmental water consists of a high density and diversity of bacterial species that form the foundation of the water ecosystem. Because the majority of these species cannot be cultured in vitro, a different approach is needed...

Cite
Akama T, Kawashima A, Tanigawa K, et al. Comprehensive analysis of prokaryotes in environmental water using DNA microarray analysis and whole genome amplification. Pathogens. 2013;2(4):591-605doi: 10.3390/pathogens2040591.
Akama, T., Kawashima, A., Tanigawa, K., Hayashi, M., Ishido, Y., Luo, Y., Hata, A., Fujitani, N., Ishii, N., & Suzuki, K. (2013). Comprehensive analysis of prokaryotes in environmental water using DNA microarray analysis and whole genome amplification. Pathogens (Basel, Switzerland), 2(4), 591-605. https://doi.org/10.3390/pathogens2040591
Akama, Takeshi, et al. "Comprehensive analysis of prokaryotes in environmental water using DNA microarray analysis and whole genome amplification." Pathogens (Basel, Switzerland) vol. 2,4 (2013): 591-605. doi: https://doi.org/10.3390/pathogens2040591
Akama T, Kawashima A, Tanigawa K, Hayashi M, Ishido Y, Luo Y, Hata A, Fujitani N, Ishii N, Suzuki K. Comprehensive analysis of prokaryotes in environmental water using DNA microarray analysis and whole genome amplification. Pathogens. 2013 Oct 30;2(4):591-605. doi: 10.3390/pathogens2040591. PMID: 25437334; PMCID: PMC4235703.
Copy Download .nbib Format: NLM
Combined small cell carcinoma of the sinonasal tract associated with syndrome of inappropriate secretion of antidiuretic hormone: A case report.

Oncology letters

Kayakabe M, Takahashi K, Okamiya T, Segawa A, Oyama T, Chikamatsu K.
PMID: 24944702
Oncol Lett. 2014 Apr;7(4):1253-1256. doi: 10.3892/ol.2014.1882. Epub 2014 Feb 13.

Combined small cell carcinoma (SmCC) and squamous cell carcinoma (SqCC) is a rare malignant neoplasm in the head and neck. This study presents the first reported case of combined SmCC and SqCC originating from the sinonasal tract accompanied by...

Cite
Kayakabe M, Takahashi K, Okamiya T, et al. Combined small cell carcinoma of the sinonasal tract associated with syndrome of inappropriate secretion of antidiuretic hormone: A case report. Oncol Lett. 2014;7(4):1253-1256doi: 10.3892/ol.2014.1882.
Kayakabe, M., Takahashi, K., Okamiya, T., Segawa, A., Oyama, T., & Chikamatsu, K. (2014). Combined small cell carcinoma of the sinonasal tract associated with syndrome of inappropriate secretion of antidiuretic hormone: A case report. Oncology letters, 7(4), 1253-1256. https://doi.org/10.3892/ol.2014.1882
Kayakabe, Mikiko, et al. "Combined small cell carcinoma of the sinonasal tract associated with syndrome of inappropriate secretion of antidiuretic hormone: A case report." Oncology letters vol. 7,4 (2014): 1253-1256. doi: https://doi.org/10.3892/ol.2014.1882
Kayakabe M, Takahashi K, Okamiya T, Segawa A, Oyama T, Chikamatsu K. Combined small cell carcinoma of the sinonasal tract associated with syndrome of inappropriate secretion of antidiuretic hormone: A case report. Oncol Lett. 2014 Apr;7(4):1253-1256. doi: 10.3892/ol.2014.1882. Epub 2014 Feb 13. PMID: 24944702; PMCID: PMC3961257.
Copy Download .nbib Format: NLM
Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir.

World journal of clinical cases

Suga T, Sato K, Yamazaki Y, Ohyama T, Horiguchi N, Kakizaki S, Kusano M, Yamada M.
PMID: 26677451
World J Clin Cases. 2015 Dec 16;3(12):1005-10. doi: 10.12998/wjcc.v3.i12.1005.

A 66-year-old, interferon-ineligible, treatment-naive man who was diagnosed with chronic hepatitis C due to hepatitis C virus genotype 1b began combination therapy with daclatasvir and asunaprevir. On day 14 of treatment, hepatic reserve and renal function deterioration was observed,...

Cite
Suga T, Sato K, Yamazaki Y, et al. Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir. World J Clin Cases. 2015;3(12):1005-10doi: 10.12998/wjcc.v3.i12.1005.
Suga, T., Sato, K., Yamazaki, Y., Ohyama, T., Horiguchi, N., Kakizaki, S., Kusano, M., & Yamada, M. (2015). Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir. World journal of clinical cases, 3(12), 1005-10. https://doi.org/10.12998/wjcc.v3.i12.1005
Suga, Takayoshi, et al. "Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir." World journal of clinical cases vol. 3,12 (2015): 1005-10. doi: https://doi.org/10.12998/wjcc.v3.i12.1005
Suga T, Sato K, Yamazaki Y, Ohyama T, Horiguchi N, Kakizaki S, Kusano M, Yamada M. Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir. World J Clin Cases. 2015 Dec 16;3(12):1005-10. doi: 10.12998/wjcc.v3.i12.1005. PMID: 26677451; PMCID: PMC4677081.
Copy Download .nbib Format: NLM
Is Occult Obscure Gastrointestinal Bleeding a Definite Indication for Capsule Endoscopy? A Retrospective Analysis of Diagnostic Yield in Patients with Occult versus Overt Bleeding.

Gastroenterology research and practice

Watari I, Oka S, Tanaka S, Nakano M, Aoyama T, Yoshida S, Chayama K.
PMID: 24324488
Gastroenterol Res Pract. 2013;2013:915463. doi: 10.1155/2013/915463. Epub 2013 Nov 12.

Background/Aim. Usefulness of capsule endoscopy (CE) for diagnosing small-bowel lesions in patients with obscure gastrointestinal bleeding (OGIB) has been reported. Most reports have addressed the clinical features of overt OGIB, with few addressing occult OGIB. We aimed to clarify...

Cite
Watari I, Oka S, Tanaka S, et al. Is Occult Obscure Gastrointestinal Bleeding a Definite Indication for Capsule Endoscopy? A Retrospective Analysis of Diagnostic Yield in Patients with Occult versus Overt Bleeding. Gastroenterol Res Pract. 2013;2013:915463doi: 10.1155/2013/915463.
Watari, I., Oka, S., Tanaka, S., Nakano, M., Aoyama, T., Yoshida, S., & Chayama, K. (2013). Is Occult Obscure Gastrointestinal Bleeding a Definite Indication for Capsule Endoscopy? A Retrospective Analysis of Diagnostic Yield in Patients with Occult versus Overt Bleeding. Gastroenterology research and practice, 2013915463. https://doi.org/10.1155/2013/915463
Watari, Ikue, et al. "Is Occult Obscure Gastrointestinal Bleeding a Definite Indication for Capsule Endoscopy? A Retrospective Analysis of Diagnostic Yield in Patients with Occult versus Overt Bleeding." Gastroenterology research and practice vol. 2013 (2013): 915463. doi: https://doi.org/10.1155/2013/915463
Watari I, Oka S, Tanaka S, Nakano M, Aoyama T, Yoshida S, Chayama K. Is Occult Obscure Gastrointestinal Bleeding a Definite Indication for Capsule Endoscopy? A Retrospective Analysis of Diagnostic Yield in Patients with Occult versus Overt Bleeding. Gastroenterol Res Pract. 2013;2013:915463. doi: 10.1155/2013/915463. Epub 2013 Nov 12. PMID: 24324488; PMCID: PMC3845716.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 979 entries